![Barry Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Simon
Director/Board Member at
IMMUNITYBIO, INC.
Net worth: 21 M $ as of 2026-05-30
Profile
Barry J. Simon occupies the position of Chairman, President & Chief Executive Officer at Brink Biologics, Inc. and Director & Chief Corporate Affairs Officer at ImmunityBio, Inc. He is also on the board of Cue Biopharma, Inc. (former Chairman) and Viracta Therapeutics, Inc. In the past Dr. Simon occupied the position of Vice President for Roche Holding AG and Vice President at Roche Diagnostics Corp. (a subsidiary of Roche Holding AG), Vice President at HealthPro BioVentures LLC, Vice President for North Sound Capital LLC, Vice President-Clinical & Regulatory Affairs at iTherX Pharmaceuticals, Inc., President, Director & Chief Administrative Officer at NantKwest, Inc. and Vice President for Immunomedics, Inc. Dr. Simon received a doctorate from State University of New York at Downstate Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNITYBIO INC 0.27% | 2026-06-03 | 2,827,788 ( 0.27% ) | 21 M $ | 2026-05-30 |
Barry Simon active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNITYBIO, INC. | Director/Board Member | 2006-12-31 |
Brink Biologics, Inc.
 Brink Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 2015-02-28 |
Former positions of Barry Simon
| Companies | Position | End |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2024-12-17 |
| CUE BIOPHARMA, INC. | Chairman | - |
| IMMUNITYBIO, INC. | Chief Executive Officer | 2015-02-28 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Director/Board Member | 2020-10-31 |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | 2004-11-30 |
Training of Barry Simon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
iTherX Pharmaceuticals, Inc.
 iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services Engages in the discovery and development of drugs and therapies | Distribution Services |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
HealthPro BioVentures LLC
 HealthPro BioVentures LLC Investment ManagersFinance HealthPro BioVentures serves the biotechnology, biomedical, healthcare and pharmaceutical sectors. Their purpose is to define, enhance and realize value for their clients by leveraging their experience, resources and network of relationships. The firm seeks to provide unparalleled services to meet the needs of the life sciences sector, from large corporate entities to emerging companies. HealthPro originally emerged from DavosPharma. They draw on extensive contacts through their relationships and association with DavosPharma. As a result, HealthPro has a network of both buy-side and sell-side healthcare opportunities. HealthPro BioVentures' services include the development of strategic and tactical themes and target lists of potential partners, access to their vast, proprietary library of available compounds, assisting with presentations and due diligence dossiers, analysis of the synergies of potential strategic partners, advising on structure, timing and pricing of transactions and assisting with negotiation, documentation and closing of transactions. HealthPro targets potential partners and investors to assist both public and private companies who are looking to acquire a strategic target company or product. The firm's portfolio of services allows them to represent life sciences companies that are either interested in being acquired or interested in investing specific assets. In both by-side and sell-side transactions, their focus is on developing transactions that are mutually beneficial to both the buyer and the seller. | Finance |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Sound Capital LLC
 North Sound Capital LLC Investment ManagersFinance North Sound is a global long/short equity hedge fund manager. Though not limited by sector, they tend to focus on large-cap companies in the finance, communications, retail, energy and consumer services sectors. | Finance |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Brink Biologics, Inc.
Brink Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
ImmunityBio, Inc.
 ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
Roche Labs |
- Stock Market
- Insiders
- Barry Simon
